Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00047
|
|||||
| Drug Name |
D-serine
|
|||||
| Synonyms |
(2R)-2-amino-3-hydroxy-propanoic acid; (2R)-2-amino-3-hydroxypropanoic acid; (2R)-serine; (R)-2-Amino-3-hydroxypropionic acid; (R)-2-amino-3-hydroxypropanoic acid; (R)-Serine; 1K77H2Z9B1; AI3-18476; CHEBI:16523; CHEMBL285123; D-2-Amino-3-hydroxypropanoic acid; D-2-Amino-3-hydroxypropionic Acid; D-Ser; D-Serin; D-Serine, 98%; DSN; EINECS 206-229-4; MFCD00004269; MTCFGRXMJLQNBG-UWTATZPHSA-N; NCGC00094363-03; NSC 77689; NSC77689; Serine D-form; Serine, D-; UNII-1K77H2Z9B1; [3h]-d-serine; d-(+)-serine; serine d-
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Serine deficiency disorder [ICD11: 5C50.6] | Phase 4 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C3H7NO3
|
|||||
| Canonical SMILES |
C(C(C(=O)O)N)O
|
|||||
| InChI |
InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m1/s1
|
|||||
| InChIKey |
MTCFGRXMJLQNBG-UWTATZPHSA-N
|
|||||
| CAS Number |
CAS 312-84-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 105.09 | Topological Polar Surface Area | 83.6 | ||
| Heavy Atom Count | 7 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
-3.1
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103060962
, 103204181
, 103822437
, 104038215
, 104349603
, 117518385
, 14747454
, 15146420
, 17405644
, 24278008
, 26718244
, 26753645
, 26753646
, 4003
, 43127470
, 46392862
, 46508200
, 47811035
, 47885661
, 48110736
, 49748509
, 49846980
, 50045910
, 50096464
, 50096469
, 50106988
, 50106989
, 53778194
, 56312452
, 56313140
, 56437651
, 57318000
, 588250
, 626975
, 7887195
, 80530258
, 8143525
, 8194408
, 829388
, 839068
, 85756772
, 87350321
, 87575662
, 87636300
, 90341480
, 92298581
, 92303181
, 92717308
, 99213597
, 99224311
|
|||||
| ChEBI ID |
ChEBI:16523
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | ASCT1 | Transporter Info | Alanine/serine/cysteine/threonine transporter 1 | Substrate | [2] | |
| ASCT2 | Transporter Info | Alanine/serine/cysteine/threonine transporter 2 | Substrate | [2] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | ASCT1 | Transporter Info | Km = 206 microM | Oocytes-ASCT1 | [2] | |
| ASCT1 | Transporter Info | Km = 2200 microM | Rat hippocampal astrocyte-ASCT1 | [2] | ||
| ASCT2 | Transporter Info | Km = 167 microM | Oocytes-ASCT2 | [2] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01018056) Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission | |||||
| 2 | D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures. PLoS One. 2016 Jun 7;11(6):e0156551. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.